Amane Takahashi

Saitama Cancer Center

Papers

1

Total Citations

9

H-Index

1

About

Dr. Amane Takahashi is a leading surgical oncologist whose work centers on advancing minimally invasive techniques for pancreatic cancer treatment. His primary research focuses on the comparative effectiveness and oncologic safety of minimally invasive distal pancreatectomy (MIDP) versus traditional open surgery. Dr. Takahashi’s most significant contribution is his leadership in the landmark JCOG2202 (LAPAN) study, a multi-institutional randomized phase III trial that directly addresses the critical question of whether MIDP—including laparoscopic and robotic approaches—can match the oncologic outcomes of open distal pancreatectomy. This pivotal work, published in 2024, has already garnered 9 citations, reflecting its immediate impact on clinical practice and surgical guidelines. By providing high-level evidence on the safety and efficacy of MIDP, Dr. Takahashi is helping to shape the future of pancreatic cancer surgery, potentially offering patients a less invasive option without compromising cancer control. His rigorous, evidence-based approach is instrumental in resolving long-standing debates within the surgical community and guiding the next generation of pancreatic surgeons.

Research Focus

Key Achievements

1
H-Index
1
Papers
9
Total Citations
9
Avg Citations/Paper
🏆 Most Cited Paper
A multi-institutional randomized phase III study comparing minimally invasive distal pancreatectomy versus open distal pancreatectomy for pancreatic cancer; Japan Clinical Oncology Group study JCOG2202 (LAPAN study)
9 citations · 2024
📈 Most Prolific Year: 2024 (1 Papers)
🤝 Key Collaborators: 26
🏛 Institutions: Saitama Cancer Center

Top Papers

  1. 1

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 12 days ago